JP2010280669A5 - - Google Patents

Download PDF

Info

Publication number
JP2010280669A5
JP2010280669A5 JP2010157000A JP2010157000A JP2010280669A5 JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5 JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
independently
case
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010157000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010280669A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010280669A publication Critical patent/JP2010280669A/ja
Publication of JP2010280669A5 publication Critical patent/JP2010280669A5/ja
Withdrawn legal-status Critical Current

Links

JP2010157000A 2002-05-21 2010-07-09 置換複素環式化合物および使用方法 Withdrawn JP2010280669A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38269902P 2002-05-21 2002-05-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004507465A Division JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Publications (2)

Publication Number Publication Date
JP2010280669A JP2010280669A (ja) 2010-12-16
JP2010280669A5 true JP2010280669A5 (enExample) 2011-10-06

Family

ID=29584444

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法
JP2010157000A Withdrawn JP2010280669A (ja) 2002-05-21 2010-07-09 置換複素環式化合物および使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Country Status (10)

Country Link
US (1) US7026326B2 (enExample)
EP (1) EP1506186A1 (enExample)
JP (2) JP4606161B2 (enExample)
AR (1) AR039842A1 (enExample)
AU (1) AU2003234628B2 (enExample)
CA (1) CA2485166A1 (enExample)
MX (1) MXPA04011470A (enExample)
PL (1) PL376575A1 (enExample)
TW (1) TW200406399A (enExample)
WO (1) WO2003099808A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06001002A (es) * 2003-07-25 2006-04-11 Amgen Inc Piridonas y pirimidinonas sustituidas con propiedades antiinflamatorias.
CA2535644A1 (en) 2003-08-20 2005-03-03 Amgen Inc. Substituted pyrimdinone derivatives and methods of use
NZ556017A (en) * 2004-12-24 2009-10-30 Prosidion Ltd G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
US7528448B2 (en) * 2006-07-17 2009-05-05 E.I. Du Pont De Nemours And Company Thin film transistor comprising novel conductor and dielectric compositions
US8062824B2 (en) 2006-07-17 2011-11-22 E. I. Du Pont De Nemours And Company Thermally imageable dielectric layers, thermal transfer donors and receivers
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
SI2203439T1 (sl) 2007-09-14 2011-05-31 Ortho Mcneil Janssen Pharm 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
US7666567B2 (en) 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Negative imaging method for providing a patterned metal layer having high conductivity
US7666568B2 (en) * 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Composition and method for providing a patterned metal layer having high conductivity
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
ES2401691T3 (es) 2008-11-28 2013-04-23 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2440001T3 (es) 2009-05-12 2014-01-27 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US9133187B2 (en) 2011-02-28 2015-09-15 Array Biopharma Inc. Serine/threonine kinase inhibitors
KR101979042B1 (ko) 2011-08-04 2019-05-15 어레이 바이오파마 인크. 세린/트레오닌 키나제 억제제로서의 퀴나졸린 화합물
WO2013066729A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
DK3321262T3 (da) 2012-03-01 2021-01-25 Array Biopharma Inc Serin-/threoninkinasehæmmere
JP6378182B2 (ja) 2012-08-27 2018-08-22 アレイ バイオファーマ、インコーポレイテッド 過剰増殖性│疾患の処置のためのセリン/スレオニンキナーゼ阻害剤
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
US10537573B2 (en) 2014-01-21 2020-01-21 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
US11178870B2 (en) * 2017-04-11 2021-11-23 Mitsui Chemicals Agro, Inc. Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients
IL302293A (en) * 2017-08-23 2023-06-01 Sprint Bioscience Ab Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
EP4056556A1 (en) * 2017-08-23 2022-09-14 Sprint Bioscience AB Pyridylpyridone compounds
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
CA3199988A1 (en) 2020-11-25 2022-06-02 Daniel L. Flynn Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection
WO2023156386A2 (en) * 2022-02-16 2023-08-24 Duke Street Bio Limited Pharmaceutical compound
CN120379982A (zh) 2022-12-02 2025-07-25 纽摩拉治疗公司 治疗神经障碍的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602794A (en) * 1952-07-08 Process for preparation of x-amino-s
WO1995009917A1 (en) 1993-10-07 1995-04-13 The Regents Of The University Of California Genetically engineered bispecific tetravalent antibodies
EP0793504B1 (en) 1994-12-12 2005-06-08 Beth Israel Deaconess Medical Center, Inc. Chimeric cytokines and uses thereof
DE69739656D1 (de) 1996-02-09 2009-12-31 Amgen Inc 1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
TW520362B (en) 1996-12-05 2003-02-11 Amgen Inc Substituted pyrimidine compounds and pharmaceutical composition comprising same
BR9713863A (pt) * 1996-12-05 2000-03-14 Amgen Inc Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, processos de profilaxia ou tratamento, para abaixar as concentrações no plasma, para diminuir a produção de prostaglandinas, e, para diminuir a atividade de enzima ciclooxigenase
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
US6410729B1 (en) * 1996-12-05 2002-06-25 Amgen Inc. Substituted pyrimidine compounds and methods of use
ES2615357T3 (es) 1996-12-06 2017-06-06 Amgen Inc. Terapia de combinación usando un inhibidor de IL-1 para tratar enfermedades mediadas por IL-1
KR19980066046A (ko) 1997-01-18 1998-10-15 정용훈 고역가의 CTLA4-Ig 융합단백질
AU7132798A (en) 1997-04-17 1998-11-11 Amgen, Inc. Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
BR0207975A (pt) * 2001-03-15 2004-06-15 Basf Ag Composto, processo para preparar 5 fenilpiridinas, produto intermediário, agente adequado para combater fungos nocivos fitopatogênicos, e, processo para combater fungos nocivos fitopatogênicos

Similar Documents

Publication Publication Date Title
JP2010280669A5 (enExample)
JP2012092103A5 (enExample)
JP2013102146A5 (ja) 化合物
JP2013521295A5 (enExample)
JP2015042636A5 (ja) 有機化合物
JP2013040159A5 (ja) 有機金属錯体
JP2014500861A5 (enExample)
JP2010241801A5 (enExample)
JP2012121883A5 (ja) オキサジアゾール誘導体
JP2016540742A5 (enExample)
JP2015505296A5 (enExample)
JP2011121940A5 (ja) 発光素子
JP2016501520A5 (enExample)
JP2010254680A5 (ja) 複素環化合物、及び発光素子
JP2013542218A5 (enExample)
JP2010095546A5 (enExample)
JP2011528706A5 (enExample)
JP2010523522A5 (enExample)
JP2013100341A5 (enExample)
JP2012109092A5 (enExample)
JP2010504286A5 (enExample)
JP2012149045A5 (ja) ベンゾ[b]ナフト[1,2−d]フラン化合物
JP2012109091A5 (enExample)
JP2014509612A5 (enExample)
JP2014526533A5 (enExample)